The USA's 5th Nationwide Health Information Network Forum, held late December 2008, in Washington DC, showcased the groundbreaking work of the Nationwide Health Information Network trial implementations which began more than 14 months ago. This work, carried out by members of a public-private "NHIN Cooperative," lays the foundation that will serve as the next step toward secure nationwide interoperable health information exchange. By making information available when and where it is needed, nationwide exchange of such data promises to increase health care quality, reducing both cost and medical errors.
Security of information and protection of privacy are essential to information exchange. In his keynote address to open the forum, US Health and Human Services Secretary Mike Leavitt announced a privacy and security doctrine, made up of eight principles, and a complete tool kit to guide efforts to ensure consumers have protected access to their health information (Privacy and Security Framework). Secretary Leavitt emphasized the relationship between these privacy and security measures and the groundbreaking technological advances demonstrated by the NHIN.
As of October 2007, several forces converged to create a broadly-based NHIN Cooperative. The HHS Department awarded contracts totaling $22.5 million to nine health information exchange organizations to begin trial implementations of the NHIN. Federal chief information officers recognized the importance of exchanging health information. As a result, the Department of Veterans Affairs, the Department of Defense, the Social Security Administration and the Indian Health Service joined the NHIN Cooperative. Since that time, the Centers for Disease Control and Prevention, the National Institutes of Health's National Cancer Institute and six additional grantees from the private sector also joined the effort.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze